Moreover, P falciparum is the only significant cause of clinical malaria in Kenya; therefore, we were unable to investigate the hypothesis that G6PD deficiency might protect against Plasmodium vivax malaria.29 This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.